BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)
CUSIP: 09075V102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
- Shares outstanding
- 239,647,920
- Total 13F shares
- 40,965,872
- Share change
- +42,564
- Total reported value
- $3,292,084,415
- Put/Call ratio
- 146%
- Price per share
- $80.36
- Number of holders
- 278
- Value change
- -$3,371,001
- Number of buys
- 117
- Number of sells
- 134
Quarterly Holders Quick Answers
What is CUSIP 09075V102?
CUSIP 09075V102 identifies BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09075V102:
Top shareholders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
|
Company |
3.5%
|
8,358,939
|
$771,112,122 | — | 31 Mar 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
2%
|
4,807,918
|
$443,530,436 | — | 31 Mar 2024 | |
| HARDING LOEVNER LP |
13F
|
Company |
1.6%
|
3,818,163
|
$352,227,770 | — | 31 Mar 2024 | |
| Se Flossbach von Storch |
13F
|
Individual |
1.4%
|
3,468,986
|
$320,013,959 | — | 31 Mar 2024 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.4%
|
3,430,250
|
$316,440,563 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.8%
|
1,906,841
|
$175,906,051 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.45%
|
1,083,910
|
$99,990,747 | — | 31 Mar 2024 | |
| Capital World Investors |
13F
|
Company |
0.39%
|
943,116
|
$87,002,451 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.35%
|
834,390
|
$76,972,445 | — | 31 Mar 2024 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.3%
|
713,383
|
$65,809,582 | — | 31 Mar 2024 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
0.3%
|
712,708
|
$65,747,314 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
598,767
|
$55,236,256 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.24%
|
569,574
|
$52,543,202 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.21%
|
497,468
|
$45,891,424 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.2%
|
478,880
|
$44,176,680 | — | 31 Mar 2024 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.17%
|
411,897
|
$38,291,000 | — | 31 Mar 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.15%
|
361,813
|
$33,377,268 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.14%
|
333,611
|
$30,775,615 | — | 31 Mar 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.11%
|
274,748
|
$25,345,503 | — | 31 Mar 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.1%
|
251,223
|
$23,175,322 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.11%
|
265,812
|
$22,905,020 | — | 31 Mar 2024 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.09%
|
216,950
|
$20,013,638 | — | 31 Mar 2024 | |
| De L'Echiquier la Financiere |
13F
|
Individual |
0.09%
|
214,112
|
$19,751,832 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.09%
|
213,989
|
$19,740,486 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.09%
|
207,631
|
$19,153,961 | — | 31 Mar 2024 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.08%
|
198,596
|
$18,320,481 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.08%
|
190,102
|
$17,536,910 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
187,644
|
$17,310,159 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.08%
|
186,756
|
$17,228,241 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.07%
|
170,172
|
$15,758,414 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.07%
|
170,000
|
$15,682,500 | — | 31 Mar 2024 | |
| AXA S.A. |
13F
|
Company |
0.07%
|
168,986
|
$15,588,959 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
162,082
|
$14,952,065 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.07%
|
160,303
|
$14,787,952 | — | 31 Mar 2024 | |
| Gates Foundation |
13F
|
Company |
0.06%
|
148,674
|
$13,715,177 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
141,449
|
$13,048,670 | — | 31 Mar 2024 | |
| Robeco Institutional Asset Management B.V. |
13F
|
Company |
0.06%
|
140,909
|
$12,998,857 | — | 31 Mar 2024 | |
| Baader Bank Aktiengesellschaft |
13F
|
Company |
0.06%
|
135,100
|
$12,459,882 | — | 31 Mar 2024 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
130,341
|
$12,023,928 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.05%
|
120,400
|
$11,106,900 | — | 31 Mar 2024 | |
| Krensavage Asset Management, LLC |
13F
|
Company |
0.05%
|
120,000
|
$11,070,000 | — | 31 Mar 2024 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.05%
|
117,709
|
$10,859,000 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.05%
|
111,398
|
$10,275,000 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.04%
|
103,858
|
$9,580,901 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.04%
|
101,486
|
$9,362,083 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
98,206
|
$9,059,504 | — | 31 Mar 2024 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.04%
|
95,822
|
$8,839,559 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
94,458
|
$8,713,750 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
92,410
|
$8,524,822 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
92,128
|
$8,498,808 | — | 31 Mar 2024 |
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q2 2024
As of 30 Jun 2024,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
278 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,965,872 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, FLOSSBACH VON STORCH AG, HARDING LOEVNER LP, BlackRock Inc., Temasek Holdings (Private) Ltd, MORGAN STANLEY, Capital World Investors, Capital International Investors, and FMR LLC.
This page lists
280
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
278
Q2 2024 holders
278
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.